Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Long-Term Debt Repayments (2021 - 2023)

GeneDx Holdings has reported Long-Term Debt Repayments over the past 2 years, most recently at $2.0 million for Q1 2023.

  • Quarterly results put Long-Term Debt Repayments at $2.0 million for Q1 2023, changed N/A from a year ago — trailing twelve months through Jun 2023 was $2.0 million (up 135.85% YoY), and the annual figure for FY2021 was $3.7 million, down 7.03%.
  • Long-Term Debt Repayments for Q1 2023 was $2.0 million at GeneDx Holdings, up from $454000.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for WGSWW hit a ceiling of $2.0 million in Q1 2023 and a floor of $394000.0 in Q1 2021.